These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 19209621)
1. Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty. Eyssette-Guerreau S; Pinto G; Sultan A; Le Merrer M; Sultan C; Polak M J Pediatr Endocrinol Metab; 2008 Oct; 21(10):995-1002. PubMed ID: 19209621 [TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole. Almeida MQ; Brito VN; Lins TS; Guerra-Junior G; de Castro M; Antonini SR; Arnhold IJ; Mendonca BB; Latronico AC Clin Endocrinol (Oxf); 2008 Jul; 69(1):93-8. PubMed ID: 18088394 [TBL] [Abstract][Full Text] [Related]
4. Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole. Kreher NC; Pescovitz OH; Delameter P; Tiulpakov A; Hochberg Z J Pediatr; 2006 Sep; 149(3):416-20. PubMed ID: 16939760 [TBL] [Abstract][Full Text] [Related]
5. Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor. Mitre N; Lteif A J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1163-7. PubMed ID: 20333877 [TBL] [Abstract][Full Text] [Related]
6. Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty. Leschek EW; Flor AC; Bryant JC; Jones JV; Barnes KM; Cutler GB J Pediatr; 2017 Nov; 190():229-235. PubMed ID: 29144249 [TBL] [Abstract][Full Text] [Related]
7. Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene. Özcabı B; Tahmiscioğlu Bucak F; Ceylaner S; Özcan R; Büyükünal C; Ercan O; Tüysüz B; Evliyaoğlu O J Clin Res Pediatr Endocrinol; 2015 Sep; 7(3):242-8. PubMed ID: 26831561 [TBL] [Abstract][Full Text] [Related]
8. Bicalutamide and third-generation aromatase inhibitors in testotoxicosis. Lenz AM; Shulman D; Eugster EA; Rahhal S; Fuqua JS; Pescovitz OH; Lewis KA Pediatrics; 2010 Sep; 126(3):e728-33. PubMed ID: 20713483 [TBL] [Abstract][Full Text] [Related]
9. Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome. Tessaris D; Matarazzo P; Mussa A; Tuli G; Verna F; Fiore L; Lala R Endocr J; 2012; 59(2):111-7. PubMed ID: 22068112 [TBL] [Abstract][Full Text] [Related]
10. Reply; Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene. Evliyaoğlu O J Clin Res Pediatr Endocrinol; 2016 Mar; 8(1):107. PubMed ID: 26757946 [No Abstract] [Full Text] [Related]
11. Long-term outcome of male-limited gonadotropin-independent precocious puberty. Bertelloni S; Baroncelli GI; Lala R; Cappa M; Matarazzo P; De Sanctis C; Saggese G Horm Res; 1997; 48(5):235-9. PubMed ID: 9362394 [TBL] [Abstract][Full Text] [Related]
12. Preclinical diagnosis of testotoxicosis in a boy with an activating mutation of the luteinizing hormone receptor. Teles M; Brito VN; Arnhold IJ; Mendonca BB; Latronico AC J Pediatr Endocrinol Metab; 2006 Apr; 19(4):541-4. PubMed ID: 16759041 [TBL] [Abstract][Full Text] [Related]
13. A Case of Familial Male-limited Precocious Puberty with a Novel Mutation. Gurnurkar S; DiLillo E; Carakushansky M J Clin Res Pediatr Endocrinol; 2021 Jun; 13(2):239-244. PubMed ID: 32757547 [TBL] [Abstract][Full Text] [Related]
14. Testotoxicosis proved by immunohistochemical analysis and successfully treated with cyproterone acetate. Itoh K; Nakada T; Kubota Y; Suzuki H; Ishigooka M; Izumi T Urol Int; 1996; 57(3):199-202. PubMed ID: 8912454 [TBL] [Abstract][Full Text] [Related]
15. The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome. Mieszczak J; Lowe ES; Plourde P; Eugster EA J Clin Endocrinol Metab; 2008 Jul; 93(7):2751-4. PubMed ID: 18397987 [TBL] [Abstract][Full Text] [Related]
16. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate). Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897 [TBL] [Abstract][Full Text] [Related]
17. Anastrozole plus leuprorelin in early maturing girls with compromised growth: the "GAIL" study. Papadimitriou DT; Dermitzaki E; Papagianni M; Papaioannou G; Papaevangelou V; Papadimitriou A J Endocrinol Invest; 2016 Apr; 39(4):439-46. PubMed ID: 26507391 [TBL] [Abstract][Full Text] [Related]
18. Combined treatment with ketoconazole and cyproterone acetate in a boy with McCune-Albright syndrome and peripheral precocious puberty. Messina MF; Arrigo T; Wasniewska M; Lombardo F; Crisafulli G; Salzano G; De Luca F J Endocrinol Invest; 2008 Sep; 31(9):839-40. PubMed ID: 18997496 [No Abstract] [Full Text] [Related]
19. Delayed closure of epiphyseal cartilages induced by the aromatase inhibitor anastrozole. Would it help short children grow up? Faglia G; Arosio M; Porretti S J Endocrinol Invest; 2000 Dec; 23(11):721-3. PubMed ID: 11194703 [TBL] [Abstract][Full Text] [Related]
20. Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome. Alves C; Silva SF J Pediatr Endocrinol Metab; 2012; 25(3-4):323-5. PubMed ID: 22774233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]